PFAS and Structural Birth Defects
Population-based studies have examined associations between residential PFAS water contamination and birth defect rates. Elevated rates of congenital heart defects, hypospadias, and certain limb reduction defects have been reported in communities with high prenatal PFAS exposure. These associations are consistent with PFAS effects on fetal signaling pathways governing organogenesis during the first trimester.
Animal teratology studies demonstrate that PFAS cause cardiac septal defects, skeletal abnormalities, and urogenital malformations at doses relevant to human occupational exposure. The mechanism involves disruption of retinoic acid signaling — a pathway essential for normal organ formation — and interference with Wnt signaling governing limb and cardiac morphogenesis.
PFAS in the NICU
Neonates in intensive care — particularly premature infants — are among the most vulnerable to PFAS exposure. NICU equipment including intravenous tubing, medical device coatings, and incubator materials may contain PFAS that leach into contact surfaces. Parenteral nutrition solutions and medical fluids may introduce additional PFAS. Premature infants who lack the protective skin barrier of full-term neonates have higher dermal PFAS absorption.
PFAS blood levels measured in NICU patients have been found to exceed those of their mothers in some studies, suggesting additional PFAS sources in the neonatal care environment. Research is ongoing to characterize NICU PFAS exposure and its effects on neurodevelopment and organ maturation in premature infants.
Clinical and Regulatory Responses
Neonatologists and NICU directors are beginning to audit materials in their units for PFAS content and work with manufacturers to identify PFAS-free alternatives for medical devices. Several academic medical centers have initiated PFAS reduction programs as part of broader environmental health and sustainability initiatives.
Parents of NICU infants should be informed that filtered water — rather than tap water — should be used for any water-based preparations including formula and oral medications wherever possible. This is particularly important in hospitals located in PFAS-contaminated water service areas.